NCT00432380View on ClinicalTrials.gov

A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants.

PHASE2CompletedINTERVENTIONAL

Enrollment

375

Participants

Timeline

Start Date

March 9, 2007

Primary Completion Date

September 4, 2007

Study Completion Date

September 4, 2007

Conditions

Infections, RotavirusRotavirus Vaccines

Interventions

BIOLOGICAL

Rotarix™

oral doses

BIOLOGICAL

Placebo

oral dose

Trial Locations (1)

Unknown

GSK Investigational Site, City of Muntinlupa

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00432380 - A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants. | Biotech Hunter | Biotech Hunter